XML 63 R38.htm IDEA: XBRL DOCUMENT
v3.25.0.1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Accounting Policies [Abstract] |
Schedule of Computation of Basic and Diluted Earnings Per Share | The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
| Years Ended December 31,
| 2024 |  | 2023 |  | 2022
Net Income for Earnings Per Share Calculations: |  |  |  |  |
Income from continuing operations, net of tax | $ | 1,396.0 |  |  | $ | 1,220.0 |  |  | $ | 1,324.0 |
Net loss attributable to noncontrolling interests | (4.9) |  |  | (3.0) |  |  | — |
Income from continuing operations attributable to Edwards Lifesciences Corporation | 1,400.9 |  |  | 1,223.0 |  |  | 1,324.0 |
Income from discontinued operations | 2,773.7 |  |  | 179.4 |  |  | 197.9 |
Net income attributable to Edwards Lifesciences Corporation | $ | 4,174.6 |  |  | $ | 1,402.4 |  |  | $ | 1,521.9 |
Weighted Average Shares: |  |  |  |  |
Basic weighted-average shares outstanding | 597.7 |  |  | 606.7 |  |  | 619.0 |
Dilutive effect of stock plans | 1.6 |  |  | 2.7 |  |  | 5.2 |
Dilutive weighted-average shares outstanding | 599.3 |  |  | 609.4 |  |  | 624.2 |
Earnings per Share: |  |  |  |  |
Basic: |  |  |  |  |
Continuing operations | $ | 2.34 |  |  | $ | 2.02 |  |  | $ | 2.14 |
Discontinued operations | 4.64 |  |  | 0.29 |  |  | 0.32 |
Basic earnings per share | $ | 6.98 |  |  | $ | 2.31 |  |  | $ | 2.46 |
Diluted: |  |  |  |  |
Continuing operations | $ | 2.34 |  |  | $ | 2.01 |  |  | $ | 2.12 |
Discontinued operations | 4.63 |  |  | 0.29 |  |  | 0.32 |
Diluted earnings per share | $ | 6.97 |  |  | $ | 2.30 |  |  | $ | 2.44 |
Schedule of Stock-Based Compensation Expense | Total stock-based compensation expense was as follows (in millions):
| Years Ended December 31,
| 2024 |  | 2023 |  | 2022
Cost of sales | $ | 26.7 |  |  | $ | 20.6 |  |  | $ | 20.3 |
Selling, general, and administrative expenses | 82.5 |  |  | 74.0 |  |  | 67.3 |
Research and development expenses | 36.4 |  |  | 30.2 |  |  | 26.0 |
Total stock-based compensation expense | 145.6 |  |  | 124.8 |  |  | 113.6 |
Income tax benefit | (24.8) |  |  | (21.8) |  |  | (19.6) |
Total stock-based compensation expense, net of tax | $ | 120.8 |  |  | $ | 103.0 |  |  | $ | 94.0 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration